OTIC 6.40 - sold the last. Just find it a bit odd that they tell shareholders in August they are cancelling a trial and then (with no update) they spring a Phase3 positive result from Europe?
Also come the Q1-filing in May their netcash should be dwindled down to about $3. Might rebuy low 4's for a flip but otherwise not interested in reentry at this time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.